Condensed Statements of Comprehensive Loss - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Statements of Comprehensive Loss [Abstract]
Sales	$ 554,908	$ 244,361	$ 1,047,532	$ 858,859
Cost of sales (excluding depreciation expense)	190,839	86,186	352,496	301,775
Operating expenses:
Research and development	2,303,241	2,072,830	6,049,847	5,137,441
Sales and marketing	1,572,189	70,883	2,847,866	444,678
General and administrative	1,530,791	1,970,408	4,645,412	4,642,182
Depreciation and amortization	76,288	125,318	215,144	391,683
Total operating expenses	5,482,509	4,239,439	13,758,269	10,615,984
Loss from operations	(5,118,440)	(4,081,264)	(13,063,233)	(10,058,900)
Other income (expense):
Interest income	124,028	92,392	532,850	232,133
Interest expense	(413,290)	(8,033)	(1,163,153)	(9,903)
Total other income (expense), net	(289,262)	84,359	(630,303)	222,230
Loss before income taxes	(5,407,702)	(3,996,905)	(13,693,536)	(9,836,670)
Income tax expense (benefit)	1,158	0	(592)	0
Net loss	(5,408,860)	(3,996,905)	(13,692,944)	(9,836,670)
Net loss attributable to common stockholders, basic	(5,408,860)	(3,996,905)	(13,692,944)	(9,836,670)
Net loss attributable to common stockholders, diluted	$ (5,408,860)	$ (3,996,905)	$ (13,692,944)	$ (9,836,670)
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.24)	$ (0.26)	$ (0.62)	$ (0.74)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.24)	$ (0.26)	$ (0.62)	$ (0.74)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)	22,232,799	15,093,147	22,075,135	13,369,462
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)	22,232,799	15,093,147	22,075,135	13,369,462